Argenica Therapeutics Ltd AGN.AX
AUD0.18
Last Updated: Aug 11, 12:00 AM·ASX
Pricing for AU stocks is delayed by 24 hours
AGN.AX Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Argenica Therapeutics Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Argenica Therapeutics Ltd. Stock Analysis AGN.AX
Australia Health Care Nano Cap Argenica Therapeutics Ltd. provides neuroprotective treatment. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2021-06-11. The firm develops neuroprotective therapeutics for patients following stroke and other acute neurological injuries. Its drug candidate, ARG-007, is designed to protect vulnerable brain tissue by reducing cell death and limiting secondary damage after an ischemic event. The firm has completed a Phase I clinical trial in healthy human volunteers to assess the safety and tolerability of a single dose of ARG-007. The company has completed a Phase II clinical trial in ischaemic stroke patients, as well as continuing to generate preclinical data in other neurological conditions. The ARG-007 has a plurifunctional mechanism of action, affecting neuronal excitotoxicity, calcium influx and mitochondrial dysfunction, and reducing the activation of damaging proteolytic enzymes which enhances its neuroprotective potential and translational clinical effectiveness.
Argenica Therapeutics Ltd (AGN.AX) Chart
Financial Metrics & Statements of Argenica Therapeutics Ltd (AGN.AX)
FAQ's for Argenica Therapeutics Ltd (AGN.AX)
- As of August 2026, Argenica Therapeutics Ltd AGN.AX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Argenica Therapeutics Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Argenica Therapeutics Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Argenica Therapeutics Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Argenica Therapeutics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Argenica Therapeutics Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Argenica Therapeutics Ltd (AGN.AX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
